We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Diversicare Healthcare Services, Inc. (“Diversicare” or the “Company”) (OTC: DVCR) in connection with the proposed acquisition of the Company by DAC Acquisition LLC.  Under the terms of the merger agreement, the Company’s shareholders will receive $10.10 per share in cash for each share of Diversicare common stock that they hold.  

WeissLaw LLP is investigating whether (i) Diversicare’sboard of directors acted in the best interests of Company shareholders inagreeing to the proposed transaction, (ii) the $10.10 per-share merger considerationadequately compensates Diversicare’s shareholders, and (iii) all informationregarding the sales process and valuation of the transaction will be fully andfairly disclosed.  

WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties.  We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases.  If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at stockinfo@weisslawllp.com

‍